Meet Our Featured Speakers
SHAPING THE FUTURE OF PEPTIDE DRUGS AND APPLICATIONS
Welcome to the Peptide Drug Summit 2026, where industry leaders meet peptide innovators to explore advanced technologies and manufacturing expertise shaping the future of the peptide field.
The healthcare industry is undergoing a technological transformation in peptide therapeutics, driving the need for improved delivery, stability, and bioavailability. Market demands and regulatory standards are pushing manufacturers to focus on efficacy and precise targeting in the development and production of future therapeutics, ensuring safety and strong clinical outcomes.
Join us to connect with experts, explore innovative strategies, and help advance the future of peptide therapeutics.
key topics for
Emerging market trends and the business outlook for future peptide drugs
Analyze peptide drug market dynamics, assess long-term potential, and identify key growth opportunities and sector-specific challenges shaping the future.
Latest advancements and strategies for scaling up peptide synthesis
Stay informed on peptide synthesis advancements using the latest techniques reshaping manufacturing standards while enhancing safety, quality, and consistency.
Case studies on peptide uses in radioconjugates and theranostic platforms
Explore peptide theragnostics and radioconjugates that demonstrate strong clinical efficacy and enable precise, targeted therapeutic outcomes in practice.
Technology-enabled discovery of novel peptides, targets, and production
Leverage advanced technologies to identify and optimize peptides and targets while streamlining manufacturing processes for increased efficiency.
Formulations, delivery methods, and applied uses of therapeutic peptides
Learn how novel peptide formulations and advanced delivery technologies improve therapeutic outcomes and elevate patient experience across treatment settings.
Regulatory frameworks and quality control strategies for peptide drugs
Discuss the evolving regulatory landscape and explore strategies to ensure compliance and maintain control throughout peptide drug development processes.
INDUSTRY TOPICS
NETWORKING EVENTS
LEADING EXPERTS
Q&A SESSIONS
Latest News
RESEARCH
27 Feb 2026
Can AI Crack the Code on Fibrosis?INNOVATION
25 Feb 2026
AI Unlocks the Secret to Cell EntryPARTNERSHIPS
24 Feb 2026
U.S. Peptide Groups Form GMP AllianceINVESTMENT
23 Feb 2026
$305mn Bet on Peptides Signals Shift in Cancer
AI-Designed Peptide Enters Late-Stage Infection Trial

INNOVATION
20 Feb 2026
Peptilogics advances zaloganan into Phase 2/3 with $120mn in funding to tackle biofilm-related joint infections
they've attended our events
Expert Speakers
Kenneth Drew
Flamma Group
Brian Kay
Tango Biosciences, Inc.
Octávio Franco
Peptidus Biotech
Past Attendees
Beam Therapeutics
Bristol Myers Squibb
Merck
BASF
IMCD US
Janssen Pharmaceutical
BD
Lubrizol
Halozyme Therapeutics























